Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Biomagnetics Diagnostics Corp. (BMGP)
Orangevale, US
Biomagnetics Diagnostics Corp. operates as a pioneering company at the forefront of advanced medical device development and biotechnology. The firm's diagnostic technologies prioritize the direct, real-time detection of viruses, toxins, or the disease itself. This approach differs significantly from traditional methods that rely on identifying antibodies, which are part of the body's immune response and can take several weeks to many months to manifest. The company's product portfolio features the High Throughput Screening - Magnetic Testing Platform (HTS-MTP) and the Integrity Optical Biosensor (IOBS). The HTS-MTP system is designed to provide comprehensive analysis from a single test, offering both qualitative identification of chemical elements within a substance and precise quantitative measurements of specific components. Furthermore, its optical biosensor operates on the principle of protein-receptor binding. It utilizes planar optical waveguides to bring together two or more optically tagged receptors, thereby inducing changes in fluorescence that are almost instantly recognized by tiny, integrated detectors.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | -90.00% | -90.00% | -90.00% | -90.00% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
-
Revenue growth Medical - Specialties: +8.3%—
-
EPS growth Medical - Specialties: +10.1%+64.0% ★
-
FCF margin FCF growth · Medical - Specialties: +51.3%—
-
EBIT margin Medical - Specialties: +12.6%—
-
ROIC Medical - Specialties: +6.6%-30.5%
-
Share dilution Medical - Specialties: 0.0%+63.8%
-
Debt / EBITDA Net debt/EBITDA · Medical - Specialties: -0.39×-1.21×
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Clayton Hardman | Founder, Chief Executive Officer, President, Acting Chief Financial Officer, Secretary & Director | — | male |
| Jose Manuel Lopez Portillo | Director and Director of Strategic Alliances & Government Affairs for Mexico | — | — |
| Paul Clayton Hardman | Chief Operating Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for BMGP
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
